Effect of Empagliflozin in diabetic nephropathy
Phase 3
- Conditions
- ephropathy and proteinuria in diabetic nephropathy patients taking empagliflozin.Diabetes mellitus due to underlying condition with diabetic nephropathyE08.21
- Registration Number
- IRCT20210906052395N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 96
Inclusion Criteria
Patient with type2 diabetes
over the age of 18 years
GFR<60 or albuminuria
Exclusion Criteria
Recent myocatdial infarction and PCI
Dialysis in the last ninety days
GFR<30
Renal failure for reasons other than diabetes
Recurrent urinary tract infections
History of amputation due to diabetes
Bladder cancer
Active diabetic foot ulcer
type 1 diabetes
Pregnancy and lactation
Major surgery performed in the last 28 days
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method